-
1
-
-
0022529134
-
Compounds extracted from feverfew that have anti-secretory activity contain an α-methylene butyrolactone unit
-
Groenewegen, W. A., Knight, D. W., Heptinstall, S.: Compounds extracted from feverfew that have anti-secretory activity contain an α-methylene butyrolactone unit. J. Pharm. Pharmac. 39: 709-712, 1987.
-
(1987)
J. Pharm. Pharmac.
, vol.39
, pp. 709-712
-
-
Groenewegen, W.A.1
Knight, D.W.2
Heptinstall, S.3
-
2
-
-
85030016235
-
The essential oil of Tanacetum parthenium (L.) Schultz-Bip
-
Accepted for publication
-
Hendriks, H., Bos, R., Woerdenbag, H. J.: The essential oil of Tanacetum parthenium (L.) Schultz-Bip. Flav. Fragr. J. Accepted for publication.
-
Flav. Fragr. J.
-
-
Hendriks, H.1
Bos, R.2
Woerdenbag, H.J.3
-
3
-
-
0021826729
-
Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes
-
Heptinstall, S., White, A., Williamson, L., Mitchell, J. R. A.: Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes. Lancet 8437: 1071-1074, 1985.
-
(1985)
Lancet
, vol.8437
, pp. 1071-1074
-
-
Heptinstall, S.1
White, A.2
Williamson, L.3
Mitchell, J.R.A.4
-
4
-
-
84965632039
-
Guidelines for controlled trials of drugs in migraine
-
First edition
-
International Headache Society Committee on Clinical Trials in Migraine. Guidelines for controlled trials of drugs in migraine. First edition. Cephalalgia 11: 1-12, 1991.
-
(1991)
Cephalalgia
, vol.11
, pp. 1-12
-
-
-
5
-
-
0021969251
-
Efficacy of feverfew as prophylactic treatment of migraine
-
Johnson, E. S., Kadam, N. P., Hylands, D. M., Hylands, P. J.: Efficacy of feverfew as prophylactic treatment of migraine. Br. Med. J. 291: 569-573, 1985.
-
(1985)
Br. Med. J.
, vol.291
, pp. 569-573
-
-
Johnson, E.S.1
Kadam, N.P.2
Hylands, D.M.3
Hylands, P.J.4
-
6
-
-
0023752998
-
Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
-
Murphy, J. J., Heptinstall, S., Mitchell, J. R. A.: Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 8604: 189-192, 1988.
-
(1988)
Lancet
, vol.8604
, pp. 189-192
-
-
Murphy, J.J.1
Heptinstall, S.2
Mitchell, J.R.A.3
-
7
-
-
0023771694
-
Prostaglandin synthetase inhibitors in feverfew
-
Pugh, W. J., Sambo, K.: Prostaglandin synthetase inhibitors in feverfew. J. Pharm. Pharmacol. 40: 743-745, 1988.
-
(1988)
J. Pharm. Pharmacol.
, vol.40
, pp. 743-745
-
-
Pugh, W.J.1
Sambo, K.2
-
8
-
-
0003678816
-
-
John Wiley & Sons, Chichester - New York - Brisbane - Toronto - Singapore
-
Senn, S.: Cross-over trials in Clinical Research. John Wiley & Sons, Chichester - New York - Brisbane - Toronto - Singapore, 1993.
-
(1993)
Cross-over Trials in Clinical Research
-
-
Senn, S.1
-
10
-
-
0027361402
-
Drug therapy of migraine
-
Welch, K. M. A.: Drug therapy of migraine. N. Eng. Med. J. 329: 1476-1483, 1993.
-
(1993)
N. Eng. Med. J.
, vol.329
, pp. 1476-1483
-
-
Welch, K.M.A.1
|